Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tianeptine for Treatment Resistant Depression

NCT04249596 is registered in ClinicalTrials.gov with Jonathan A. Javitch, MD, PhD as lead sponsor.

NCT NCT04249596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04249596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tianeptine for Treatment Resistant Depression
Lead sponsor
Jonathan A. Javitch, MD, PhD
Phase
Phase 4
Overall status
Terminated
Start date
October 14, 2020
Completion date
August 27, 2024
Enrollment
38 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression